Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
AACR Journals: Simultaneous Publication Options Cancer Discovery publishes high-impact, peer-reviewed articles describing major advances in research and clinical trials. As the premier cancer information resource, the Journal also presents Review Articles, Perspectives and Commentaries, News stories, and Research Watch summaries of important journal articles to its readers to keep them informed about the latest findings in the field. Topics span the spectrum of cancer research and medicine from the laboratory to the clinic and epidemiologic studies. Current Impact Factor: 19.783 Published Daily Online; Monthly in Print Editorial Board Editors-in-Chief: Lewis C. Cantley and José Baselga About the Journal Cancer Immunology Research publishes outstanding original articles reporting major advances in cancer immunology that span the discipline from basic investigations in host-tumor interactions to developmental therapeutics in model systems, early translational studies in patients, and late-stage clinical trials. The journal disseminates knowledge of immunology to the cancer research community, catalyzing cross-disciplinary work that yields a deeper understanding of the host-tumor relationship, more potent cancer treatments, and improved clinical outcomes. Papers are stringently reviewed, and specific topics of interest include endogenous antitumor immunity, tumor-promoting inflammation, cancer antigens, vaccines, antibodies, cellular therapy, cytokines, immune regulation, immune suppression, immunomodulatory effects of cancer treatment, emerging technologies, and clinical investigations. The journal's special features include "Masters of Immunology"—primers by leading immunologists—and "Cancer Immunology at the Crossroads"— perspectives that highlight the intersection of immunology with other areas of cancer research and allied disciplines. Current Impact Factor: 6.665 Published Daily Online; Monthly in Print Editorial Board Editors-in-Chief: Robert D. Schreiber and Philip D. Greenberg About the Journal Clinical Cancer Research — A Journal of Clinical and Translational Research — focuses on innovative clinical research and translational research that bridges the laboratory and the clinic. Clinical Cancer Research presents clinical trials evaluating new treatments for cancer; research on molecular abnormalities that predict incidence, response to therapy, and outcome; and laboratory studies of new drugs and biomarkers that will lead to clinical trials in patients. Current Impact Factor: 8.738 Published Daily Online; Semi Monthly in print Editorial Board Editor-in-Chief: Kenneth C. Anderson About the Journal Molecular Cancer Therapeutics — Integrating Targets, Therapeutics, and Technologies — strives to be the top choice for publishing the best science in the discovery and preclinical development of novel therapeutic agents for oncology, preclinical studies of approved therapeutics, mechanisms of drug action, mechanisms of drug resistance, biomarkers of drug response, novel models and technologies, and occasional drug toxicity mechanisms. While the Journal's main focus is on small molecule and protein drugs, other molecular entities may be considered. Current Impact Factor: 5.579 Published Daily Online; Monthly in print Editorial Board Editor-in-Chief: Napoleone Ferrara About the Journal »» Submit a Manuscript to Molecular Cancer Therapeutics